Monitoring Response To Neoadjuvant Chemotherapy- Contrast Enhanced Mammography Versus Magnetic Resonance Imaging. A Non Inferiority Study (Joint with University of Warwick and Cheltenham and Gloucestershire Hospitals NHS Trust) (Stage 1 application) (CESAR)